Find your next paid study

City of Hope Medical CenterNCT06815003

Phase 3

A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel-group, Pivotal Trial to Assess the Efficacy and Safety of Sonlicromanol in Adult Subjects With a Genetically Confirmed Mitochondrial DNA tRNALeu(UUR) m.3243A>G Variant

The KHENERFIN study aims to determine whether the study medicine, sonlicromanol, is able to reduce symptoms of fatigue and the impact of fatigue on daily life,…

Mitochondrial DiseasesMaternally Inherited Diabetes and Deafness (MIDD)Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like Episodes (MELAS)+1 more

~$10 – $7,500

Khondrion BVNCT06451757

Single Sided DeafnessUnilateral DeafnessHearing Loss, Unilateral+3 more

Cochlear Implantation in Infants and Toddlers With Single-Sided Deafness

The goal of this clinical trial is to investigate the safety and effectiveness of cochlear implantation in infants and toddlers with single-sided deafness. Th…

University of North Carolina, Chapel HillNCT05775367

SchizophreniaSchizoaffective Disorder

Optimizing Cognitive Behavioral Social Skills Training With Executive Function Training for Older Adults With Schizophrenia

This randomized controlled clinical trial will test a blended intervention that combines Executive Function Training with Cognitive-Behavioral Skills Training …

University of California, San DiegoNCT07658391

StrokeSpinal Cord Injuries and DisordersHemiparesis After Stroke

Spinal Cord Stimulation Combined With Physical Therapy in Post-Stroke Upper-Limb Motor Hemiparesis

This study plans to use systems that have been developed by Medtronic to investigate the use of cervical spinal cord stimulation to treat adults with upper lim…

Marco CapogrossoNCT07153536

~$10 – $7,500

Reversal of Lipid-Induced Insulin Resistance

The purpose of this study is to examine whether weight reduction decreases intramyocellular (IMCL) and hepatic lipid content, and improves insulin sensitivity …

Insulin ResistanceNAFLD

Yale UniversityNCT02193295

Phase 2

A Phase II b Study of Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease

The purpose of this study is to see whether giving participants a combination treatment of Axatilimab and Extracorporeal Photopheresis (ECP) is effective again…

Chronic Graft Versus Host DiseasecGVHD

University of MiamiNCT06663722

Phase 3

A Phase 3, Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

The primary objective of this study is to demonstrate the efficacy of ravulizumab vs placebo in reducing the severity of DGF as measured by time to freedom fro…

Delayed Graft FunctionDGFKidney Transplant

Alexion Pharmaceuticals, Inc.NCT06830798

~$10 – $8,750

A Prospective, Multi-Center, Open-Label Clinical Investigation of the Cleaner Vac® Thrombectomy System for Treatment of Lower Extremity Proximal Deep Vein Thrombosis (DVT)

The primary objective of this clinical investigation is to evaluate the safety and effectiveness of the Cleaner Vac® Thrombectomy System for the treatment of t…

Deep Vein Thrombosis (DVT)Thrombus in the Peripheral Venous VasculatureVenous Embolism+1 more

Argon Medical DevicesNCT07102160

~$10 – $1,125

Phase 2

AGAVE-201, A Phase 2, Open-label, Randomized, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of Axatilimab at 3 Different Doses in Patients With Recurrent or Refractory Active Chronic Graft Versus Host Disease Who Have Received at Least 2 Lines of Systemic Therapy

This is a Phase 2 study to evaluate the efficacy, safety, and tolerability of axatilimab at 3 different dose levels in participants with recurrent or refractor…

Chronic Graft-versus-host-disease

Syndax PharmaceuticalsNCT04710576

~$10 – $8,750

Phase 1

Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of Oral MG001

This research study is the first time the new medication MG001 is being tested in people. MG001 is a formulation of mitragynine, a compound that comes from a p…

Safety and Tolerability in Healthy Subjects

National Institute on Drug Abuse (NIDA)NCT07204171

~$10 – $5,625

Atrial Fibrillation (AF)Pulmonary Embolism (PE)Left Atrial Appendage Thrombosis

Exclusion of Left Atrial Appendage Thrombus in Emergency Department Patients With Atrial Fibrillation Undergoing CT to Assess for Pulmonary Embolus: A Feasibility Study

This study aims to investigate whether a quick, additional CT scan of the heart, performed immediately after a standard CT scan for pulmonary embolism, can eff…